Active substance
Idoxuridine
- SFDA 1
- US FDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| COLIRCUSI VIRUCIDE 0.2% | 0.2 % | Eye drops · Ocular use | 1 Dropper Container | SAR 9.70 | NCE · Prescription | ALCON CUSI | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| HERPLEX | 0.1% | solution/drops · ophthalmic | ALLERGAN | Discontinued | 11 Jun 1963 |
| DENDRID | 0.1% | solution/drops · ophthalmic | ALCON | Discontinued | 28 Jun 1963 |
| STOXIL | 0.1% | solution/drops · ophthalmic | GLAXOSMITHKLINE | Discontinued | 6 Apr 1964 |
| STOXIL | 0.5% | ointment · ophthalmic | GLAXOSMITHKLINE | Discontinued | 2 Sep 1967 |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.